![]() |
Volumn 59, Issue 1, 2001, Pages 1-3
|
Do we have a new standard of treatment for patients with seminoma stage IIA and stage IIB?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOPLATIN;
CANCER ADJUVANT THERAPY;
CANCER EPIDEMIOLOGY;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
EDITORIAL;
HUMAN;
PRIORITY JOURNAL;
SEMINOMA;
TREATMENT OUTCOME;
TREATMENT PLANNING;
CARBOPLATIN;
COMBINED MODALITY THERAPY;
CONTROLLED CLINICAL TRIALS;
HUMANS;
MALE;
NEOPLASM STAGING;
PROGNOSIS;
RADIATION DOSAGE;
RADIOTHERAPY;
SEMINOMA;
SURVIVAL RATE;
TESTICULAR NEOPLASMS;
|
EID: 0035313798
PISSN: 01678140
EISSN: None
Source Type: Journal
DOI: 10.1016/S0167-8140(01)00344-9 Document Type: Editorial |
Times cited : (10)
|
References (18)
|